期刊文献+

经尿道钬激光膀胱肿瘤切除术和膀胱肿瘤电切术治疗表浅层膀胱癌的疗效比较 被引量:59

Efficacy and safety of transurethral holmium laser resection and standard transurethral electroresection in patients with superficial bladder cancer
暂未订购
导出
摘要 目的观察经尿道钬激光膀胱肿瘤切除术(HoLRBT)和经尿道膀胱肿瘤电切术(TURBT)治疗浅表层膀胱癌的疗效和安全性。方法我院于2011年6月到2013年6月收治行手术治疗的表浅层膀胱癌患者271例,根据治疗方法分为HoLRBT组和TURBT组。分别对2组患者手术时间、术中出血量、膀胱冲洗时间、尿管留置时间、住院时间等术中术后情况、手术并发症和2年累积复发率进行比较分析。结果 2组手术时间比较无统计学意义(P>0.05)。HoLRBT组术中出血量、膀胱冲洗时间、尿管留置时间和住院时间明显低于TURBT组,差异有统计学意义(P<0.05)。HoLRBT组患者术后并发症的发生率明显低于TURBT组,差异有统计学意义(P<0.05)。HoLRBT组和TURBT组患者2年累积复发率分别为8%和16.67%,HoLRBT组复发率明显低于TURBT组,差异有统计学意义(P<0.05)。结论 HoLRBT治疗表浅层膀胱癌疗效显著,安全可靠,可显著降低术后复发率,值得临床推广使用。 Objective To compare the efficacy and safety of transurethral holmium laser resection (HoLRBT) and stand- ard transurethral electroresection (TURBT) in patients with superficial bladder cancer. Methods A total of 251 patients with superficial bladder cancer from 3une 2011 to .lune 2013 were divided into the HoLRBT group and TURBT group. The operative time, the blood loss, bladder irrigation time, catheter indwelling time, hospitalization time, complication and cumulative re- currence rate were analyzed. Results There was no statistical significance between the HoLRBT group and TURBT group (P ~0.05). The operative time, the blood loss, bladder irrigation time, catheter indwelling time and hospitalization time in the HoLRBT group were significantly lower than those of the TURBT group (P〈0.05). The incidence rate of complications in the HoLRBT group were significantly lower than that of the TURBT group (P〈O. 05). The cumulative recurrence rate in the HoLRBT group and TURBT group were 8% and 16. 67%, with significant difference between the two groups (P〈O. 05). Oonclusiorl HoLRBT is worthy of clinical application for good efficacy and safety and lower recurrence rate in patients with su- perficial bladder cancer.
出处 《现代泌尿外科杂志》 CAS 2014年第2期108-110,共3页 Journal of Modern Urology
关键词 经尿道钬激光膀胱肿瘤切除术 经尿道膀胱肿瘤电切术 表浅层膀胱癌 疗效 安全性 transurethral holmium laser resection standard transurethral electroresection superficial bladder cancer efficacy safety
  • 相关文献

参考文献6

二级参考文献30

  • 1沈肖曹,杜传军,史时芳,陈继民,经宵.经尿道钬激光切除与经尿道电切治疗浅表性膀胱肿瘤的疗效比较[J].中华泌尿外科杂志,2005,26(1):30-32. 被引量:42
  • 2HUANGJian XUKe-wei YAOYou-sheng GUOZheng-hui XIEWen-lian JIANGChun HANJin-li LISi-yao.Laparoscopic radical cystectomy with orthotopic ileal neobladder: report of 33 cases[J].Chinese Medical Journal,2005(1):27-33. 被引量:21
  • 3叶敏.T_1期膀胱移行细胞癌的现代处理[J].临床泌尿外科杂志,2005,20(8):450-452. 被引量:7
  • 4许振强,郑周达,庄志明,陈森期,张朝贤,林海利.经尿道膀胱肿瘤电切术105例报告[J].临床泌尿外科杂志,2005,20(12):739-740. 被引量:49
  • 5Sengnpta S,Bluteml ML.The management of superficial transitional cell carcinoma of the bladder[J].Urology,2006,67(3Suppl 1):48-54.
  • 6Metts MC,Metts JC,Milito SJ,et al.Bladder cancer:a review of diagnosis and management[J].J Natl Med Assoc,2000,92(6):285-294.
  • 7Holzbeierlein JM,Smith JA Jr.Surgical management of noninvasive bladder cancer(stages Ta/TI/CIS)[J].Urol Clin North Am,2000,27(1):15-24.
  • 8Nakagawa S,Kojima M,Takada H,et al.Short-duration bladder instillation therapy with pirarubicin for superficial bladdet tumor based on pharmacodynamic study[J].Gan To Kagaku Ryoho,1992,19(11):1873-1877.
  • 9Pawinski A, Sylvester R, Kurth KH, et al. A combined analysis of european organization for research and treatment of cancer, and medical research council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. EORTC and the medical research council working party on superficial bladder cancer [ J ]. J Urol, 1996,156 (6) : 1934-1940.
  • 10Sylvester R J, van der Meijden AP, Oosterlinck W, et al. Predicting recurrence and progression in individual patients with stage TaT1 bladder cancer using EORTC risk tables: a combined analysis of 2 596 patients from seven EORTC trials [ J ]. Eur Urel, 2006,49 (3) :466-477.

共引文献84

同被引文献296

引证文献59

二级引证文献222

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部